The impact of COVID 19 outbreak on noncommunicable disease (NCDs) patients in Map Ta Phut district, Rayong province

Authors

  • Somchai Pairpiroon Memorial Hospital Sirindhorn, Rayong
  • Chan Pattama Polyong Bansomdejchaopraya Rajabhat University 0000-0002-6971-6336
  • Ammara Bunsarai Memorial Hospital Sirindhorn, Rayong
  • Marissa Kongsombatsuk Memorial Hospital Sirindhorn, Rayong

DOI:

https://doi.org/10.14456/dcj.2023.3

Keywords:

clinical outcomes, noncommunicable disease (NCDs), before COVID-19 pandemic, during COVID-19 pandemic, Map Ta Phut

Abstract

           The purpose of this descriptive study is to investigate the impact of the COVID-19 epidemic on the noncommunicable disease patient group in Map Ta Phut District, Rayong Province.The parameters study were body mass index, waist circumference, blood pressure, blood sugar levels, blood lipids, and kidney function. The sample consisted of 385 noncommunicable disease patients obtained from Hosxp program of hospital medical records and collected in 2019-2020 years; data were analyzed using descriptive statistics as follows: amount, percentage, mean, standard deviation, and percentage of change; The statistical significance for the inferential statistics used to compare by paired sample t-test.

            The findings revealed that there were more female patients than males, with a ratio of 1.34 : 1.00, a mean age of 57.9±11.1 years, and that 72.7 percent were occupations, wherewith 53.5 percent were general employee. Patients had a percentage increase in triglycerides and blood sugar between before the epidemic Compared between before the epidemic (2019), and during the COVID-19 epidemic (2020), patients had a percentage increase in triglycerides and blood sugar 7.76%, and 5.87%, respectively; Statistical testing revealed that during the epidemic period, patients had statistically significant (p<0.05) higher resting blood pressure, blood sugar, low density lipoprotein, cholesterol, and triglyceride levels than before the epidemic. The patients' creatinine levels were significantly lower than before the epidemic (p<0.05). Conclusion, NCDs' patients was health risk status than it was before the epidemic; recommendations should include a health promotion program that encourages patient knowledge and a self-monitoring system tailored to living-at-home situations, including convenient channels for accessing and communicating appropriate health information.

Author Biography

Chan Pattama Polyong, Bansomdejchaopraya Rajabhat University

Assistant Professor (Occupational health and safety)

References

World Health Organization (WHO). Key facts noncommunicable diseases [Internet]. 2021 [cited 2021 Aug 15]. Available from: https://www.who.int/news-room/fact-sheets/detail/ noncommunicable-diseases

World Health Organization (WHO). Noncommunicable diseases [Internet]. 2021 [cited 2021 Aug 15]. Available from: https://www.who.int/health-topics/noncommunicable-diseases #tab=tab_1

Division of Noncommunicable Diseases (TH). Number and rate of morbidity/death 2016-2019 (hypertension, coronary disease, cerebrovascular disease, bronchitis and emphysema) per 100,000 populations (including all diagnoses) [Internet]. 2020 [cited 2021 Aug 15]. Available from: http://www.thaincd.com/2016/mission/ documents-detail.php?id=13893&tid =32&gid=1-020 (in Thai)

Aekplakorn W. (Editor). The report of the Thai people’s health survey by physical examination No. 6 (2019-2020). Graphic and design publisher. Bangkok. 2021.

Horton R. COVID-19: a new lens for non-communicable diseases. Lancet Glob Health 2021;8:e1003-17.

Azarpazhooh RM, Morovatdar N, Avan A, Thanh PG, Divani AA, Yassi N, et al. COVID-19 pandemic and burden of non-communicable diseases: an ecological study on data of 185 countries. J Stroke Cerebrovasc Dis. 2020;29:1-9.

Chen N, Zhou M, Dong X. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–13.

Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) Outbreak. J Autoimmun [Internet]. 2020 [cited 2021 Sep 7];109. Available from: https://doi.org/10. 1016/j.jaut.2020.102433

World Health Organization (WHO). WHO director-General’s opening remarks at the median briefing on COVID-19 – 11 March 2020 [Internet]. 2022 [cited 2022 Apr 8]. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020

World Health Organization (Thailand). Situation of coronavirus disease 2019 (COVID-19) in Thailand as of March 9, 2022 [Internet]. 2022 [cited 2022 Apr 9]. Available from: https://reliefweb.int/sites/reliefweb. int/files/resources/2022_03_09_tha-sitrep-226-covid-19_th.pdf (in Thai)

Singh AK, Gupta R, Ghosh A, Misra A. Diabetes in covid-19: Prevalence, pathophysiology, prognosis and practical considerations. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020;14:303-10.

Diksha A, Priyanka J, Barkha G. Diabetes and covid-19: A review. Int J Res Pharm Sci. 2020;11:376-97.

Zhang J, Wu J, Sun X, Xue H, Shao J, Cai W, et al. Associations of hypertension with the severity and fatality of SARS-CoV-2 infection: a meta-analysis. Epidemiol Infect. 2020;148:1-7.

World Health Organization (WHO). COVID-19 significantly impacts health services for noncommunicable diseases [Internet]. 2022 [cited 2022 Apr 9]. Available from: https://www.who.int/news/item/01-06-2020-covid-19-significantly-impacts-health-services-for-noncommunicable-diseases

Division of Noncommunicable Diseases (TH). The impact of COVID-19 on the non-communicable disease service system. Nonthaburi: Division of Noncommunicable Diseases; 2021. (in Thai)

Chang AY, Cullen MR, Harrington RA, Barry M. The impact of novel coronavirus COVID-19 on noncommunicable disease patients and health systems: a review. J Intern Med. 2020;289:450-62.

Racha R, Kongros J, Sodchien T. The development of nursing service system for chronic non-communicable diseases (NCDs) patients in the COVID-19 outbreak situation. Region 4-5 Medicine Journal. 2020;39(3):414-26. (in Thai)

Hernandez-Galdamez DR, Gonzalez-Block MA, Romo-Duenas DK, Lima-Morales R, Hernandez-Vicente IA, Lumbreras-Guzman M, et al. Increased risk of hospitalization and death in patients with COVID-19 and pre-existing noncommunicable diseases and modifiable risk factors in Mexico. Arch Med Res. 2020;51:683-9.

Chailak P, Sunongbua A. The outcome of diabetic patients care during the prevention of covid-19 pandemic situation at Mueang Chaiyaphum Primary Care Unit, 2020, Chaiyaphum Medicine Journal. 2021;41:111-21. (in Thai)

International Diabetes Federation (IDF). The IDF consensus worldwide definition of the metabolic syndrome [Internet]. 2021 [cited 2021 Nov 3]. Available from: https://www.idf.org/component/attachments/attachments.html?id=705&task=download

The Royal College Physicians of Thailand. General Practitioner [Internet]. 2021 [cited 2021 Nov 3]. Available from: http://www.rcpt.org/index.php/news/2012-09-24-09-26-20.html (in Thai)

Ministry of Public Health. Health knowledge and health warning [Internet]. [cited 2021 Dec 2]. Available from: http://healthydee.moph.go.th/view_article.php?id=915. (in Thai)

Fongsiripaibol S, Yuenyong N, Kulkeratiyut S. Understanding and interpreting of preliminary laboratory results for annual health checkup. PTU Journal of Science and Technology. 2021; 2:116-32. (in Thai)

Charungthanakij N. Outcomes of glycemic control in patients with type 2 diabetes receiving new services from diabetes clinic, Sai Ngam Hospital during Covid-19 pandemic. Regional Health Promotion Center 9 Journal. 2020;15:129-42. (in Thai)

Department of Disease Control (TH). Situation report of NCDs, diabetes, high blood pressure and factors related, 2019. Nonthaburi: Department of Disease Control; 2019. (in Thai)

Radhakrishnan R. Why is my bottom blood pressure number high [Internet]. [cited 2022 May 10]. Available from: https://www.medicinenet.com/why_is_my_bottom_blood_pressure_number_high/article.html

Salari N, Hosseinian-Far A, Jalali R, Vaisi-Raygani A, Rasoulpoor S, Mohammadi M, et al. Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: asystematic review and meta-analysis. Globalization and Health. 2020;16:1-11.

Gao C, Cai Y, Zhang K, Zhou L, Zhang Y, Zhang X, et al. Association of hypertension and antihypertensive treatment with COVID-19 mortality: A retrospective observational study. Eur Heart J. 2020;41:2058-66.

Ghesquiere L, Garabedian C, Drumez E, Lemaitre M, Cazaubiel M, Bengler C, et al. Effects of COVID-19 pandemic lockdown on gestational diabetes mellitus: A retrospective study. Diabetes Metabol. 2021;47:101-201.

Perrone MA, Feola A, Pieri M, Donatucci B, Salimei C, Lombardo M, et al. The effects of reduced physical activity on the lipid profile in patients with high cardiovascular risk during COVID-19 lockdown. Int J Environ Res Public Health [Internet]. 2021 [cited 2021 Nov 7];18: 8858. Available from: https://doi.org/10.3390/ijerph18168858

Capaldo B, Annuzzi G, Creanza A, Giglio C, Angelis RD, Lupoli R, et al. Blood glucose control during lockdown for COVID-19: CCM metrics in Italian adults with type 1 diabetes. Diabetes Care. 2020;43:88-9.

Baxmann AC, Ahmed MS, Marques NC, Menon VB, Pereira AB, Kirsztajn GM, et al. Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clin J Am Soc Nephrol. 2008;3:348-54.

Kirwan R, McCullough D, Butler T, Heredia FP, Davies IG, Stewart C. Sarcopenia during COVID-19 lockdown restrictions: long-term health effects of short-term muscle loss. GeroScience. 2020;42:1547-78.

Flatt JP. Use and storage of carbohydrate and fat. Am J Clin Nutr. 1995;61:952-9.

Yamaoka K, Tango T. Effects of lifestyle modification on metabolic syndrome: a systematic review and meta-analysis. BMC Med. 2012;10:138-47.

Singsawad S, Nicharojana LO, Piaseu N. Impact of Hula Hoop-assisted exercise on healthcare personel’s perceived self-efficacy, waistlines and levels of HDL cholesterol and triglyceride. Thai Journal of Nursing Council. 2012;27:109-22. (in Thai)

Downloads

Published

2023-03-25

How to Cite

1.
Pairpiroon S, Polyong CP, Bunsarai A, Kongsombatsuk M. The impact of COVID 19 outbreak on noncommunicable disease (NCDs) patients in Map Ta Phut district, Rayong province. Dis Control J [Internet]. 2023 Mar. 25 [cited 2024 May 10];49(1):21-35. Available from: https://he01.tci-thaijo.org/index.php/DCJ/article/view/254788

Issue

Section

Original Article